Company Filing History:
Years Active: 1997-1999
Title: The Innovations of Samuel Kayman
Introduction
Samuel Kayman is a notable inventor based in New York, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of fusion glycoproteins. With a total of 2 patents to his name, Kayman's work has implications for various applications in health and medicine.
Latest Patents
Kayman's latest patents focus on novel expression vectors for expressing fusion glycoproteins. These fusion glycoproteins contain the N-terminal globular domain of a retroviral env surface protein linked to a selected glycopeptide. The vectors allow for the expression of both truncation glycoproteins and insertion glycoproteins, showcasing the versatility and potential of his innovations.
Career Highlights
Samuel Kayman is affiliated with the Public Health Research Institute of the City of New York, Inc. His work at this institution has allowed him to explore and develop groundbreaking technologies that contribute to public health advancements.
Collaborations
Kayman has collaborated with various professionals in his field, including his coworker Abraham Pinter. These collaborations have fostered an environment of innovation and have led to the successful development of his patented technologies.
Conclusion
Samuel Kayman is a distinguished inventor whose work in fusion glycoproteins has the potential to impact the field of biotechnology significantly. His contributions continue to advance public health research and innovation.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.